Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$432/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Globe Newswire News Releases

May 06, 2024 07:00 ET
Agios to Present at the BofA Securities 2024 Health Care Conference on May 16, 2024
Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today announced that the company is scheduled to present at the BofA Securities 2024 Health Care Conference on...
May 06, 2024 07:00 ET
Apellis Pharmaceuticals to Host a Fireside Chat at the Bank of America Securities Healthcare Conference
Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will host a fireside chat at the Bank of America Securities Healthcare Conference on Tuesday, May 14, 2024, at 8:00 a.m. PT. The live conference webcast will be posted...
May 06, 2024 07:00 ET
Axsome Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today announced financial results for the first quarter of 2024. “The...
May 06, 2024 07:00 ET
BioCryst Reports First Quarter 2024 Financial Results and Provides Business Update
BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today reported financial results for the first quarter ended March 31, 2024, and provided a corporate update. “We are off to a fantastic start to the year with outstanding ORLADEYO revenue growth and...
May 06, 2024 07:00 ET
Brookfield Asset Management and Castlelake to Enter into Strategic Partnership
Brookfield Asset Management (NYSE: BAM, TSX: BAM) (“Brookfield”) and Castlelake L.P. (“Castlelake”), an alternatives asset manager specializing in asset-based private credit including aviation and specialty finance, today announced that they have...
May 06, 2024 07:00 ET
Cara Therapeutics to Announce First Quarter 2024 Financial Results on May 13, 2024
Cara Therapeutics, Inc. (Nasdaq: CARA), a development-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus, today announced the Company will report first quarter 2024 financial...
May 06, 2024 07:00 ET
CW Petroleum Corp (CWPE) Submits Application to List on OTCQB
CW Petroleum Corp (CWPE) (the “Company”), a leading provider of Specialty Renewable and Hydrocarbon Motor Fuels, today announced that it has applied with OTC Markets to list its security, CWPE, on the OTCQB Exchange. Chief Executive Officer...
May 06, 2024 07:00 ET
EyePoint Pharmaceuticals Announces Topline Data from the Phase 2 PAVIA Trial of DURAVYU™ in Non-Proliferative Diabetic Retinopathy
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, today announced topline results of its Phase 2 PAVIA clinical trial...
May 06, 2024 07:00 ET
Foghorn Therapeutics Provides First Quarter 2024 Financial and Corporate Update
Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression, today provided a financial and corporate update in conjunction...
May 06, 2024 07:00 ET
GXO to Manage Logistics Operations for Levi Strauss & Co at State-of-the-Art German Distribution Center
GXO Logistics, Inc. (NYSE: GXO), the world’s largest pure-play contract logistics provider, today announced a 20-year partnership agreement with Levi Strauss & Co (LS&Co.) to manage operations at a state-of-the-art 70,000 square meter Dorsten...
May 06, 2024 07:00 ET
Inari Medical to Participate in the 2024 Bank of America Securities Healthcare Conference
Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced today its management team will present at the upcoming Bank of...
May 06, 2024 07:00 ET
Join Mobilicom’s Exclusive Live Investor Webinar and Q&A Session on May 9
Mobilicom Limited (Nasdaq: MOB), a provider of cybersecurity and robust solutions for drones and robotics, is pleased to invite investors to a webinar on May 9, 2024, at 4:15 p.m. ET. The exclusive event, hosted by RedChip Companies, will...
May 06, 2024 07:00 ET
KP Tissue Announces Filing and Mailing of the Management Proxy Materials in Connection with its 2024 Annual Meeting of Shareholders
KP Tissue Inc. (“KPT” or the “Company”) (TSX:KPT) is pleased to announce its notice of annual meeting of shareholders and management information circular (the “Circular”) are now available on KPT’s website www.kptissueinc.com as well as under KPT’s...
May 06, 2024 07:00 ET
LOBO EV Reports Fiscal Year 2023 Results and Sets Stage for Accelerating Growth in 2024
LOBO EV Technologies Ltd. (Nasdaq: LOBO) (“LOBO” or the “Company”), an innovative electric vehicle manufacturer and seller, today announced its financial results for the fiscal year ended December 31, 2023. 2023 Highlights Generated $15.5...
May 06, 2024 07:00 ET
LSL Pharma Group Enters Into Binding Agreement to Acquire Quebec Competitor
LSL PHARMA GROUP INC. (TSXV: LSL) ("the Company" or "LSL Pharma"), a Canadian integrated pharmaceutical company, is pleased to announce that it has entered into a binding Letter of Intent ("LOI") to acquire profitable privately held, Quebec-based...
May 06, 2024 07:00 ET
Mikra Announces Joint Product with Jose Bautista
Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to build breakthrough ventures that transform human wellness, is pleased...
May 06, 2024 07:00 ET
Neumora Therapeutics to Participate in Upcoming Conferences in May
Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of seven clinical and pre-clinical brain disease programs, today announced that the Company will participate in two...
May 06, 2024 07:00 ET
Osisko Metals Announces Updated Mineral Resource Estimate at Gaspé Copper – Indicated Resource of 495 Mt Grading 0.37% Copper Equivalent
Osisko Metals Incorporated (the "Company" or "Osisko Metals") (TSX-V: OM; OTCQX: OMZNF; FRANKFURT: 0B51) is pleased to announce an updated Mineral Resource Estimate (“MRE”) at Copper Mountain as part of the Gaspé Copper Project, located near...
May 06, 2024 07:00 ET
The Simply Good Foods Company to Participate in the Goldman Sachs Global Staples Forum
The Simply Good Foods Company (NASDAQ:SMPL) (“Simply Good Foods” or the “Company”), a developer, marketer and seller of branded nutritional foods and snacking products, today announced that members of the executive management team will participate...
May 06, 2024 07:00 ET
Voyager Therapeutics Announces First Quarter 2024 Conference Call and Webcast
Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced it will report first quarter 2024 financial and operating results after market close on Monday, May 13, 2024....